Pediatric Hematology/Oncology and ImmunopathologyPediatric Hematology/Oncology and ImmunopathologyВопросы гематологии/онкологии и иммунопатологии в педиатрии1726-17082414-9314Fund Doctors, Innovations, Science for Children77410.24287/1726-1708-2023-22-4-177-185LITERATURE REVIEWОБЗОР ЛИТЕРАТУРЫEpithelial malignant tumors of the parotid salivary glands in children and adolescentsЭпителиальные злокачественные опухоли околоушных слюнных желез у детей и подростковhttps://orcid.org/0000-0002-6839-39188416-5222KalininaM. P.КалининаМ. П.
Russian Federation

Margarita P. Kalinina, an otorhinolaryngologist at the Department of  Oncology and Pediatric Surgery

1 Samory Mashela St., Moscow 117997

Калинина Маргарита Павловна, врач-оториноларинголог отделения онкологии и детской хирургии

117997, Москва, ул. Саморы Машела, 1

lormp@yandex.ruhttps://orcid.org/0000-0002-4451-3233GrachevN. S.ГрачевН. С.
Russian Federation

Moscow

Москва

nick-grachev@yandex.ruDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian FederationФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России201220232241771851310202317102023Copyright ©; 2023, «D. Rogachev NMRCPHOI»Copyright ©; 2023, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России2023«D. Rogachev NMRCPHOI»ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава Россииhttps://creativecommons.org/licenses/by/4.0https://hemoncim.com/jour/article/view/774

The article provides data on epithelial malignant tumors of the parotid salivary glands in children and adolescents. We present a historical background and modern classification proposed by the World Health Organization in 2022. We present the evolution of surgical and non-surgical treatment methods used in pediatric oncology.

В статье представлены данные об эпителиальных злокачественных опухолях околоушных слюнных желез у детей и подростков. Приведены историческая справка и современная классификация, предложенная Всемирной организацией здравоохранения в 2022 г. Представлена эволюция методов хирургического и нехирургического лечения, применяемых в детской онкологии.

epithelial malignant tumors of the salivary glandsparotid salivary glandchildrenadolescentsэпителиальные злокачественные опухоли слюнных железоколоушная слюнная железадетиподросткиReferencesEthunandan M., Ethunandan A., Macpherson D.W., Conroy B., Pratt C. Parotid neoplasms in children: experience of diagnosis and management in a district general hospital. Int J Oral Maxillofac Surg 2003; 32 (4): 373–7.Ethunandan M, Ethunandan A, Macpherson DW, Conroy B, Pratt C. Parotid neoplasms in children: experience of diagnosis and management in a district general hospital. Int J Oral Maxillofac Surg. 2003 Aug;32(4):373–7.De Ribeiro K.C.B., Kowalski L.P., Saba L.M.B., De Camargo B. Epithelial salivary glands neoplasms in children and adolescents: a fortyfour-year experience. Med Pediatr Oncol 2002; 39 (6): 594–600.De Ribeiro KCB, Kowalski LP, Saba LMB, De Camargo B. Epithelial salivary glands neoplasms in children and adolescents: a forty-four-year experience. Med Pediatr Oncol. 2002 Dec;39(6):594–600.Yoshida E.J., García J., Eisele D.W., Chen A.M. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol 2014; 78 (2): 174–8.Yoshida EJ, García J, Eisele DW, Chen AM. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol. 2014 Feb;78(2):174–8.Zamani M., Grønhøj C., Schmidt Jensen J., von Buchwald C., Charabi B.W., Hjuler T. Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta-analysis. Pediatr Blood Cancer 2019; 66 (3): e27543. DOI: 10.1002/pbc.27543Zamani M, Grønhøj C, Schmidt Jensen J, von Buchwald C, Charabi BW, Hjuler T. Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta-analysis. Pediatr Blood Cancer. 2019 Mar;66(3). DOI: 10.1002/pbc.27543Jensen J.S., Grønhøj C., Garset-Zamani M., Westergaard-Nielsen M., Bjørndal K., Kiss K., et al. Incidence and survival of salivary gland cancer in children and young adults in Denmark: A nation-wide study for the period 1990–2015. Int J Pediatr Otorhinolaryngol 2021; 143: 110637. DOI: 10.1016/j.ijporl.2021.110637Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, et al. Management of Salivary Gland Malignancy: ASCO Guideline. 2021.Available from: www.asco.org/head-neck-cancer-guidelines.Ullah A., Khan J., Waheed A., Karki N.R., Goodbee M., Yasinzai A.Q.K., et al. Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management. Cancers (Basel) 2023; 15 (1): 250. DOI: 10.3390/cancers15010250Jensen JS, Grønhøj C, Garset-Zamani M, Westergaard-Nielsen M, Bjørndal K, Kiss K, et al. Incidence and survival of salivary gland cancer in children and young adults in Denmark: A nation-wide study for the period 1990–2015. Int J Pediatr Otorhinolaryngol. 2021 Apr;143. DOI: 10.1016/j.ijporl.2021.110637Geiger J.L., Ismaila N., Beadle B., Caudell J.J., Chau N., Deschler D., et al. Management of Salivary Gland Malignancy: ASCO Guideline. J Clin Oncol 2021; 39 (17): 1909–41.Ullah A, Khan J, Waheed A, Karki NR, Goodbee M, Yasinzai AQK, et al. Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management. Cancers (Basel). 2023 Jan;15(1). DOI: 10.3390/cancers15010250Surun A., Schneider D.T., Ferrari A., Stachowicz-Stencel T., Rascon J., Synakiewicz A., et al. Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations. Pediatr Blood Cancer 2021; 68 (S4). DOI: 10.1002/pbc.29058WHO Classification of Tumours Editorial Board. Head and neck tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 (WHO classification of tumours series, 5th ed.; vol. 9. Интернет ресурс : https://tumourclassification.iarc.who.int/chapters/52[Electronic resource] BlueBooksOnline. URL: https://tumourclassification.iarc.who.int/chaptercontent/52/53 (accessed 07.10.2023).Seifert G, Brocheriou C, Cardesa A, Eveson JW. WHO International Histological Classification of Tumours Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract. 1990 Oct;186(5):555–81.Seifert G., Brocheriou C., Cardesa A., Eveson J.W. WHO International Histological Classification of Tumours Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract 1990; 186 (5): 555–81.Skálová A, Hyrcza MD, Leivo I. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head Neck Pathol. 2022 Mar;16(1):40–53.Skálová A., Hyrcza M.D., Leivo I. Update from the 5th Ed. of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head Neck Pathol 2022; 16 (1): 40–53.IARC Publications Website - Paediatric Tumours [Internet]. [cited 2023 Oct 6]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Paediatric-Tumours-2023[Electronic resource] IARC Publications Website – Paediatric Tumours. URL: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Paediatric-Tumours-2023 (accessed 06.10.2023).Aro K, Leivo I, Mäkitie A. Management of salivary gland malignancies in the pediatric population. Curr Opin Otolaryngol Head Neck Surg. 2014;22(2):116–20.Aro K., Leivo I., Mäkitie A. Management of salivary gland malignancies in the pediatric population. Curr Opin Otolaryngol Head Neck Surg 2014; 22 (2): 116–20.Sultan I, Rodriguez-Galindo C, Al-Sharabati S, Guzzo M, Casanova M, Ferrari A. Salivary gland carcinomas in children and adolescents: A population-based study, with comparison to adult cases. Head Neck. 2011 Oct;33(10):1476–81.Sultan I., Rodriguez-Galindo C., Al-Sharabati S., Guzzo M., Casanova M., Ferrari A. Salivary gland carcinomas in children and adolescents: A population-based study, with comparison to adult cases. Head Neck 2011; 33 (10): 1476–81.Laikui L, Hongwei L, Hongbing J, Zhixiu H. Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases. Journal of Oral Pathology & Medicine. 2008 Apr;37(4):201–5.Laikui L., Hongwei L., Hongbing J., Zhixiu H. Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases. J Oral Pathol Med 2008; 37 (4): 201–5.Liu B, Liu JY, Zhang WF, Jia J. Pediatric parotid tumors: Clinical review of 24 cases in a Chinese population. Int J Pediatr Otorhinolaryngol. 2012 Jul;76(7):1007–11.Liu B., Liu J.Y., Zhang W.F., Jia J. Pediatric parotid tumors: Clinical review of 24 cases in a Chinese population. Int J Pediatr Otorhinolaryngol 2012; 76 (7): 1007–11.Lennon P, Silvera VM, Perez-Atayde A, Cunningham MJ, Rahbar R. Disorders and Tumors of the Salivary Glands in Children. Otolaryngol Clin North Am. 2015 Feb;48(1):153–73.Lennon P., Silvera V.M., Perez-Atayde A., Cunningham M.J., Rahbar R. Disorders and Tumors of the Salivary Glands in Children. Otolaryngol Clin North Am 2015; 48 (1): 153–73.Rzepakowska A, Osuch-Wójcikiewicz E, Sobol M, Cruz R, Sielska-Badurek E, Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. European Archives of Oto-Rhino-Laryngology. 2017 Aug;274(8):3231–40.Rzepakowska A., Osuch-Wójcikiewicz E., Sobol M., Cruz R., Sielska-Badurek E., Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol 2017; 274 (8): 3231–40.Zheng M, Plonowska KA, Strohl MP, Ryan WR. Surgeon-performed ultrasound for the assessment of parotid masses. Am J Otolaryngol. 2018 Sep;39(5):467–71.Zheng M., Plonowska K.A., Strohl M.P., Ryan W.R. Surgeon-performed ultrasound for the assessment of parotid masses. Am J Otolaryngol 2018; 39 (5): 467–71.Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, et al. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clinical Cancer Research. 2016 Feb;22(3):725–33.Mitani Y., Liu B., Rao P.H., Borra V.J., Zafereo M., Weber R.S., et al. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res 2016; 22 (3): 725–33.Liu Y, Li J, Tan YR, Xiong P, Zhong LP. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Feb;119(2):238-245.e2.Liu Y., Li J., Tan Y.R., Xiong P., Zhong L.P. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119 (2): 238–45.e2.Paris J, Facon F, Pascal T, Chrestian MA, Moulin G, Zanaret M. Preoperative diagnostic values of fine-needle cytology and MRI in parotid gland tumors. European Archives of Oto-Rhino-Laryngology. 2005 Jan;262(1):27–31.Paris J., Facon F., Pascal T., Chrestian M.A., Moulin G., Zanaret M. Preoperative diagnostic values of fine-needle cytology and MRI in parotid gland tumors. Eur Arch Otorhinolaryngol 2005; 262 (1): 27–31.Kato H, Kanematsu M, Watanabe H, Mizuta K, Aoki M. Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology. 2014 Sep;56(9):789–95.Kato H., Kanematsu M., Watanabe H., Mizuta K., Aoki M. Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology 2014; 56 (9): 789–95.Aulino JM, Kirsch CFE, Burns J, Busse PM, Chakraborty S, Choudhri AF, et al. ACR Appropriateness Criteria ® Neck Mass-Adenopathy. Journal of the American College of Radiology. 2019 May;16(5):S150–60.Aulino J.M., Kirsch C.F.E., Burns J., Busse P.M., Chakraborty S., Choudhri A.F., et al. ACR Appropriateness Criteria® Neck Mass-Adenopathy. J Am Coll Radiol 2019; 16 (5): S150–60.Inohara H, Akahani S, Yamamoto Y, Hattori K, Tomiyama Y, Tomita Y, et al. The role of fine-needle aspiration cytology and magnetic resonance imaging in the management of parotid mass lesions. Acta Otolaryngol. 2008;128(10):1152–8.Inohara H., Akahani S., Yamamoto Y., Hattori K., Tomiyama Y., Tomita Y., et al. The role of fine-needle aspiration cytology and magnetic resonance imaging in the management of parotid mass lesions. Acta Otolaryngol 2008; 128 (10): 1152–8.Alibek S, Zenk J, Bozzato A, Lell M, Grunewald M, Anders K, et al. The Value of Dynamic MRI Studies in Parotid Tumors. Acad Radiol. 2007 Jun;14(6):701–10.Alibek S., Zenk J., Bozzato A., Lell M., Grunewald M., Anders K., et al. The Value of Dynamic MRI Studies in Parotid Tumors. Acad Radiol 2007; 14 (6): 701–10.. Zheng Y, Xiao Z, Zhang H, She D, Lin X, Lin Y, et al. Differentiation between benign and malignant palatal tumors using conventional MRI: a retrospective analysis of 130 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Apr;125(4):343–50.Zheng Y., Xiao Z., Zhang H., She D., Lin X., Lin Y., et al. Differentiation between benign and malignant palatal tumors using conventional MRI: a retrospective analysis of 130 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125 (4): 343–50.Celebi I, Mahmutoglu AS, Ucgul A, Ulusay SM, Basak T, Basak M. Quantitative diffusion-weighted magnetic resonance imaging in the evaluation of parotid gland masses: A study with histopathological correlation. Clin Imaging. 2013 Mar;37(2):232–8.Celebi I., Mahmutoglu A.S., Ucgul A., Ulusay S.M., Basak T., Basak M. Quantitative diffusion-weighted magnetic resonance imaging in the evaluation of parotid gland masses: A study with histopathological correlation. Clin Imaging 2013; 37 (2): 232–8.Ma G, Zhu LN, Su GY, Hu H, Qian W, Bu SS, et al. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors. European Archives of Oto-Rhino-Laryngology. 2018 Aug;275(8):2151–7.Ma G., Zhu L.N., Su G.Y., Hu H., Qian W., Bu S.S., et al. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors. Eur Arch Otorhinolaryngol 2018; 275 (8): 2151–7.Zhang Z, Song C, Zhang Y, Wen B, Zhu J, Cheng J. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging. Dentomaxillofacial Radiology. 2019;48(7). DOI: 10.1259/DMFR.20190100Zhang Z., Song C., Zhang Y., Wen B., Zhu J., Cheng J. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging. Dentomaxillofac Radiol 2019; 48 (7): 20190100. DOI: 10.1259/DMFR.20190100. Kim MJ, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, et al. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: Preoperative planning for necessity and extent of neck dissection. Ann Surg Oncol. 2013 Mar;20(3):899–905.Thariat J., Vedrine P.O., Orbach D., Marcy P.Y., Badoual C., Butori C., et al. Tumeurs malignes des glandes salivaires chez l’enfant. Bull Cancer 2011; 98 (7): 847–55.Roh J-L, Hwan Ryu C, Choi S-H, Seung Kim J, Hyun Lee J, Cho K-J, et al. Clinical Utility of 18 F-FDG PET for Patients with Salivary Gland Malignancies. 2007.Kim M.J., Kim J.S., Roh J.L., Lee J.H., Cho K.J., Choi S.H., et al. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: Preoperative planning for necessity and extent of neck dissection. Ann Surg Oncol 2013; 20 (3): 899–905.Cermik TF, Mavi A, Acikgoz G, Houseni M, Dadparvar S, Alavi A. FDG PET in detecting primary and recurrent malignant salivary gland tumors. Clin Nucl Med. 2007 Apr;32(4):286–91.Roh J.-L., Hwan Ryu C., Choi S.-H., Seung Kim J., Hyun Lee J., Cho K.-J., et al. Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies. J Nucl Med 2007; 48 (2): 240–6.Kim BS, Kim SJ, Pak K. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors. Ann Nucl Med. 2016 Jun;30(5):346–54.Cermik T.F., Mavi A., Acikgoz G., Houseni M., Dadparvar S., Alavi A. FDG PET in detecting primary and recurrent malignant salivary gland tumors. Clin Nucl Med 2007; 32 (4): 286–91.Ashraf A, Shaikh AS, Kamal F, Sarfraz R, Bukhari MH. Diagnostic reliability of FNAC for salivary gland swellings: A comparative study. Diagn Cytopathol. 2010 Jul;38(7):499–504.Kim B.S., Kim S.J., Pak K. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors. Ann Nucl Med 2016; 30 (5): 346–54.Carrillo JF, Ramírez R, Flores L, Ramirez-Ortega MC, Arrecillas MD, Ibarra M, et al. Diagnostic accuracy of fine needle aspiration biopsy in preoperative diagnosis of patients with parotid gland masses. J Surg Oncol. 2009 Aug;100(2):133–8.Ashraf A., Shaikh A.S., Kamal F., Sarfraz R., Bukhari M.H. Diagnostic reliability of FNAC for salivary gland swellings: A comparative study. Diagn Cytopathol 2010; 38 (7): 499–504.Eytan DF, Yin LX, Maleki Z, Koch WM, Tufano RP, Eisele DW, et al. Utility of preoperative fine needle aspiration in parotid lesions. Laryngoscope. 2018 Feb;128(2):398–402.Carrillo J.F., Ramírez R., Flores L., Ramirez-Ortega M.C., Arrecillas M.D., Ibarra M., et al. Diagnostic accuracy of fine needle aspiration biopsy in preoperative diagnosis of patients with parotid gland masses. J Surg Oncol 2009; 100 (2): 133–8.Fakhry N, Santini L, Lagier A, Dessi P, Giovanni A. Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. Int J Oral Maxillofac Surg. 2014 Jul;43(7):802–5.Eytan D.F., Yin L.X., Maleki Z., Koch W.M., Tufano R.P., Eisele D.W., et al. Utility of preoperative fine needle aspiration in parotid lesions. Laryngoscope 2018; 128 (2): 398–402.Gudmundsson JK, Ajan A, Abtahi J. The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients. J Appl Oral Sci. 2016 Nov;24(6):561–7.Fakhry N., Santini L., Lagier A., Dessi P., Giovanni A. Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. Int J Oral Maxillofac Surg 2014; 43 (7): 802–5.Altin F, Alimoglu Y, Acikalin RM, Yasar H. Is fine needle aspiration biopsy reliable in the diagnosis of parotid tumors? Comparison of preoperative and postoperative results and the factors affecting accuracy. Braz J Otorhinolaryngol. 2019 May;85(3):275–81.Gudmundsson J.K., Ajan A., Abtahi J. The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients. J Appl Oral Sci 2016; 24 (6): 561–7.Schmidt RL, Hall BJ, Wilson AR, Layfield LJ. A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Parotid Gland Lesions. Am J Clin Pathol. 2011 Jul;136(1):45–59.Altin F., Alimoglu Y., Acikalin R.M., Yasar H. Is fine needle aspiration biopsy reliable in the diagnosis of parotid tumors? Comparison of preoperative and postoperative results and the factors affecting accuracy. Braz J Otorhinolaryngol 2019; 85 (3): 275–81.Kim BY, Hyeon J, Ryu G, Choi N, Baek CH, Ko YH, et al. Diagnostic accuracy of fine needle aspiration cytology for high-grade salivary gland tumors. Ann Surg Oncol. 2013 Jul;20(7):2380–7.Schmidt R.L., Hall B.J., Wilson A.R., Layfield L.J. A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Parotid Gland Lesions. Am J Clin Pathol 2011; 136 (1): 45–59.Lin AC, Bhattacharyya N. The Utility of Fine Needle Aspiration in Parotid Malignancy. Otolaryngology–Head and Neck Surgery. 2007 May;136(5):793–8.Lin A.C., Bhattacharyya N. The Utility of Fine Needle Aspiration in Parotid Malignancy. Otolaryngol Head Neck Surg 2007; 136 (5): 793–8.Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008 Jun;36(6):425–37.Baloch Z.W., LiVolsi V.A., Asa S.L., Rosai J., Merino M.J., Randolph G., et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008; 36 (6): 425–37.Schmidt RL, Hall BJ, Layfield LJ. A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions. Am J Clin Pathol. 2011 Oct;136(4):516–26.Schmidt R.L., Hall B.J., Layfield L.J. A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions. Am J Clin Pathol 2011; 136 (4): 516–26.Kim HJ, Kim JS. Ultrasound-guided core needle biopsy in salivary glands: A meta-analysis. Laryngoscope. 2018 Jan;128(1):118–25.Kim H.J., Kim J.S. Ultrasound-guided core needle biopsy in salivary glands: A meta-analysis. Laryngoscope 2018; 128 (1): 118–25.Cho J, Kim J, Lee JS, Chee CG, Kim Y, Choi S Il. Comparison of core needle biopsy and fine-needle aspiration in diagnosis of ma lignant salivary gland neoplasm: Systematic review and meta-analysis. Head Neck. 2020 Oct;42(10):3041–50.Cho J., Kim J., Lee J.S., Chee C.G., Kim Y., Choi S.I. Comparison of core needle biopsy and fine-needle aspiration in diagnosis of ma lignant salivary gland neoplasm: Systematic review and meta-analysis. Head Neck 2020; 42 (10): 3041–50.Romano EB, Wagner JM, Alleman AM, Zhao L, Conrad RD, Krempl GA. Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors. Laryngoscope. 2017 Nov;127(11):2522–7.Romano E.B., Wagner J.M., Alleman A.M., Zhao L., Conrad R.D., Krempl G.A. Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors. Laryngoscope 2017; 127 (11): 2522–7.Griffith CC, Pai RK, Schneider F, Duvvuri U, Ferris RL, Johnson JT, et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol. 2015 Jun;143(6):839–53.Griffith C.C., Pai R.K., Schneider F., Duvvuri U., Ferris R.L., Johnson J.T., et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol 2015; 143 (6): 839–53.Wei S, Layfield LJ, LiVolsi VA, Montone KT, Baloch ZW. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review. Diagn Cytopathol. 2017 Sep;45(9):820–7.Wei S., Layfield L.J., LiVolsi V.A., Montone K.T., Baloch Z.W. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review. Diagn Cytopathol 2017; 45 (9): 820–7.Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol. 2017 Oct;125(10):757–66.Rossi E.D., Faquin W.C., Baloch Z., Barkan G.A., Foschini M.P., Pusztaszeri M., et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol 2017; 125 (10): 757–66.Farahani SJ, Baloch Z. Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature. Diagn Cytopathol. 2019 Feb;47(2):67–87.Farahani S.J., Baloch Z. Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature. Diagn Cytopathol 2019; 47 (2): 67–87.Park W, Bae H, Park MH, Hwang NY, Sohn I, Cho J, et al. Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology. J Oral Pathol Med. 2019 Mar;48(3):222–31.Park W., Bae H., Park M.H., Hwang N.Y., Sohn I., Cho J., et al. Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology. J Oral Pathol Med 2019; 48 (3): 222–31.Johnson DN, Onenerk M, Krane JF, Rossi ED, Baloch Z, Barkan G, et al. Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel. Cancer Cytopathol. 2020 Jun;128(6):392–402.Johnson D.N., Onenerk M., Krane J.F., Rossi E.D., Baloch Z., Barkan G., et al. Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel. Cancer Cytopathol 2020; 128 (6): 392–402.Jo VY, Krane JF. Ancillary testing in salivary gland cytology: A practical guide. Cancer Cytopathol. 2018 Aug;126:627–42.Jo V.Y., Krane J.F. Ancillary testing in salivary gland cytology: A practical guide. Cancer Cytopathol 2018; 126: 627–42.Bishop JA, Yonescu R, Batista DAS, Westra WH, Ali SZ. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol. 2013 May;121(5):228–33.Bishop J.A., Yonescu R., Batista D.A.S., Westra W.H., Ali S.Z. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol 2013; 121 (5): 228–33.Sun T, Akalin A, Dresser K, Fischer AH, Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol. 2021 Jun;15(2):389–94.Sun T., Akalin A., Dresser K., Fischer A.H., Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol 2021; 15 (2): 389–94.Darras N, Mooney KL, Long SR. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms. J Am Soc Cytopathol. 2019 May;8(3):157–64.Darras N., Mooney K.L., Long S.R. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms. J Am Soc Cytopathol 2019; 8 (3): 157–64.Ryan JT, El-Naggar AK, Huh W, Hanna EY, Weber RS, Kupferman ME. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011 Dec;33(12):1769–73.Ryan J.T., El-Naggar A.K., Huh W., Hanna E.Y., Weber R.S., Kupferman M.E. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck 2011; 33 (12): 1769–73.Spiro RH. Salivary neoplasms: Overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986 Jan;8(3):177–84.Spiro R.H. Salivary neoplasms: Overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8 (3): 177–84.Fushimi C, Tada Y, Takahashi H, Nagao T, Ojiri H, Masubuchi T, et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Annals of Oncology. 2018 Apr;29(4):979–84.Fushimi C., Tada Y., Takahashi H., Nagao T., Ojiri H., Masubuchi T., et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 2018; 29 (4): 979–84.Qureshi SS, Bhagat M, Singhal N, Tathe N, Kembhavi S, Laskar S, et al. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children. Head Neck. 2016 Jun;38(6):852–6.Qureshi S.S., Bhagat M., Singhal N., Tathe N., Kembhavi S., Laskar S., et al. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children. Head Neck 2016; 38 (6): 852–6.Morse E, Fujiwara RJT, Judson B, Prasad ML, Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. Laryngoscope. 2019 Jan;129(1):129–37.Xiao C.C., Zhan K.Y., White-Gilbertson S.J., Day T.A. Predictors of Nodal Metastasis in Parotid Malignancies. Otolaryngol Head Neck Surg 2016; 154 (1): 121–30.North L, Stadler M, Massey B, Campbell B, Shukla M, Awan M, et al. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. Am J Otolaryngol. 2019 Nov;40(6):102282.Morse E., Fujiwara R.J.T., Judson B., Prasad M.L., Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. Laryngoscope 2019; 129 (1): 129–37.Zenga J, Parikh AS, Emerick KS, Lin DT, Faquin WC, Deschler DG. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. JAMA Otolaryngol Head Neck Surg. 2018 Nov;144(11):1011.North L., Stadler M., Massey B., Campbell B., Shukla M., Awan M., et al. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. Am J Otolaryngol 2019; 40 (6): 102282.Stodulski D, Mikaszewski B, Majewska H, Wiśniewski P, Stankiewicz C. Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: Outcome of watch and wait policy. Oral Oncol. 2017 May;68:1–4.Zenga J., Parikh A.S., Emerick K.S., Lin D.T., Faquin W.C., Deschler D.G. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. JAMA Otolaryngol Head Neck Surg 2018; 144 (11): 1011.Zenga J, Yu Z, Parikh A, Chen JX, Lin DT, Emerick KS, et al. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. ORL. 2019 Apr;81(1):55–62.Stodulski D., Mikaszewski B., Majewska H., Wiśniewski P., Stankiewicz C. Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: Outcome of watch and wait policy. Oral Oncol 2017; 68: 1–4.Glas AS, Vermey A, Hollema H, Robinson PH, Roodenburg JLN, Nap RE, et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients. Head Neck. 2001 Apr;23(4):311–6.Zenga J., Yu Z., Parikh A., Chen J.X., Lin D.T., Emerick K.S., et al. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. ORL J Otorhinolaryngol Relat Spec 2019; 81 (1): 55–62.Xiao CC, Zhan KY, White-Gilbertson SJ, Day TA. Predictors of Nodal Metastasis in Parotid Malignancies. Otolaryngology–Head and Neck Surgery. 2016 Jan;154(1):121–30.Glas A.S., Vermey A., Hollema H., Robinson P.H., Roodenburg J.L.N., Nap R.E., et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients. Head Neck 2001; 23 (4): 311–6.Wang YL, Li DS, Gan HL, Lu ZW, Li H, Zhu GP, et al. Predictive index for lymph node management of major salivary gland cancer. Laryngoscope. 2012 Jul;122(7):1497–506.Wang Y.L., Li D.S., Gan H.L., Lu Z.W., Li H., Zhu G.P., et al. Predictive index for lymph node management of major salivary gland cancer. Laryngoscope 2012; 122 (7): 1497–506.Ali S, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol. 2014 Apr;21(9):3042–8.Ali S., Palmer F.L., DiLorenzo M., Shah J.P., Patel S.G., Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol 2014; 21 (9): 3042–8.Lim CM, Gilbert M, Johnson JT, Kim S. Is level V neck dissection necessary in primary parotid cancer? Laryngoscope. 2015 Jan;125(1):118–21.Lim C.M., Gilbert M., Johnson J.T., Kim S. Is level V neck dissection necessary in primary parotid cancer? Laryngoscope 2015; 125 (1): 118–21.Said M.S. Outcomes of Pediatric Patients with Malignancies of the Major Salivary Glands. Yearbook of Pathology and Laboratory Medicine 2011; 2011: 181–2.Wang X., Luo Y., Li M., Yan H., Sun M., Fan T. Management of salivary gland carcinomas-a review. 2017. Available from: www.impactjournals.com/oncotarget.Consensus Formalisé d’Experts.Grant S.R., Grosshans D.R., Bilton S.D., Garcia J.A., Amin M., Chambers M.S., et al. Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics. Radiother Oncol 2015; 116 (2): 309–15.Drilon A., Siena S., Ou S.H.I., Patel M., Ahn M.J., Lee J., et al. Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov 2017; 7 (4): 400–9.Drilon A., Laetsch T.W., Kummar S., DuBois S.G., Lassen U.N., Demetri G.D., et al. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children. N Engl J Med 2018; 378 (8): 731–9.